Standard Operating Procedure Deliverable Preparation. March 15, 2012 Version 1.0

Size: px
Start display at page:

Download "Standard Operating Procedure Deliverable Preparation. March 15, 2012 Version 1.0"

Transcription

1 Standard Operating Procedure Deliverable Preparation March 15, 2012 Version 1.0

2 Table of Contents Introduction SOP Training Roles and Responsibilities Deliverable Preparation Process Deliverable Preparation Process Flow Deliverable Preparation Process Description Draft Deliverable Draft Deliverable Preparation Draft Deliverable Review by MSOC Leadership and Submission to FDA COTR Draft Deliverable Review by FDA COTR Final Deliverable Final Deliverable Preparation Final Deliverable Review by MSOC Leadership and Submission to FDA COTR Final Deliverable Acceptance by FDA COTR Posting Deliverable Formatting Deliverable for Posting Approval of Formatted Deliverable by MSOC Leadership and Submission to FDA Sentinel Core Team for Review Approval of Formatted Deliverable for Posting by FDA Sentinel Core Team Authorization of Deliverable for Posting by MSOC Posting of Deliverable SOP - Deliverable Preparation March 15, 2012

3 Introduction Mini-Sentinel is a pilot project being conducted under contract with the U.S. Food and Drug Administration (FDA) to inform and facilitate development of a fully operational active surveillance system, the Sentinel System, for monitoring the safety of FDA-regulated medical products. Given Mini-Sentinel s large number of participating organizations, its interdependency across organizations and between core work streams, and its scale of surveillance activity, formal Standard Operating Procedures (SOPs) are needed to support the program. SOPs are detailed written procedures that establish bases for management control throughout Mini-Sentinel operations. Each SOP describes a process and provides instruction about how to perform that process by detailing key steps, roles and responsibilities, and decision making authorities. SOPs also provide the Mini-Sentinel Operations Center (MSOC) with bases for evaluating and improving processes. Purpose and Scope This SOP defines the Deliverable Preparation Process. Deliverables are final work products that fulfill contract requirements included in an FDA-issued Statement of Work. Deliverables may include, but are not limited to, scientific white papers, protocols developed for protocol-based assessments, reports from protocol-based assessments, and other project reports. Specific steps are delineated for preparation, review, revision, approval, and posting of Mini-Sentinel project deliverables. The SOP also indicates the individual or group responsible for each function. This SOP adheres to current Mini- Sentinel principles and policies as specified in the Mini-Sentinel statement of Principles and Policies. The Deliverable Preparation SOP will be implemented upon approval by the Mini-Sentinel Operations Center (MSOC) and the FDA s Contracting Officer s Technical Representative (COTR). Individuals affected by this SOP will be trained accordingly. The SOP will be revised as appropriate with the approval of the MSOC and the FDA. SOP Training All Process Participants whose work involves a particular SOP will be trained on that SOP within 30 days of 1) approval of the SOP or 2) initial engagement with a project for which the SOP is relevant. A schedule for training sessions will be provided by the SOP Manager. SOP - Deliverable Preparation March 15, 2012

4 Roles and Responsibilities Table 1 describes the roles and responsibilities associated with the Deliverable Preparation Process. Table 1: Deliverable Preparation Roles and Responsibilities Role Name Location General Responsibilities Specific Responsibilities FDA COTR and Sentinel Core Team MSOC Leadership Project Manager FDA MSOC MSOC Responsible for reviewing, accepting, and approving draft and final deliverables Responsible for overseeing preparation of draft and final deliverables and submitting them to FDA for review, acceptance, and approval Responsible for coordinating production of draft and final deliverables Review and comment on draft deliverable Accept final deliverable Approve deliverable (e.g., protocol, white paper) for posting on the Mini-Sentinel website** **Only done by Sentinel Core Team Participate in revising and editing deliverables (drafts and final), as appropriate Submit deliverables to FDA and back to Workgroup Leader as needed Send FDA-accepted deliverable to Webmaster for any additional formatting Authorize posting of FDA-approved deliverable Notify FDA of deliverable posting Ensure that Workgroup has necessary materials and resources to prepare deliverable Coordinates iterations of the draft deliverable between the Workgroup, MSOC, and/or FDA Ensure that all relevant project participants are engaged in the deliverable preparation process Webmaster MSOC Responsible for final document preparation and posting of final deliverable on MS website Workgroup Collaborators, MSOC, and/or FDA Responsible for preparing draft and final project deliverables Format FDA-accepted final deliverable in Mini-Sentinel deliverable template Verify compliance with Section 508 (accessibility of deliverable content) Post final deliverable on Mini-Sentinel website Prepare draft and final project deliverables SOP - Deliverable Preparation March 15, 2012

5 Deliverable Preparation Process The Deliverable preparation process provides procedures for managing the preparation, review, revision, approval, and posting of final project deliverables. All drafts, revisions and final deliverables will be sent via or secure portal as appropriate. Deliverable Preparation Process Flow The figure below depicts the Deliverable Preparation process. There are 6 roles in the process. Workgroup roles are in orange, MSOC roles are in green, and FDA roles are in purple. The workflow follows the numerical order illustrated. Figure 1: Deliverable Preparation Process Flow SOP - Deliverable Preparation March 15, 2012

6 Deliverable Preparation Process Description Process steps required for Deliverable Preparation are detailed below. Participating roles for each process step are indicated. 1 Draft Deliverable Prepare draft project deliverable, review and submit to FDA COTR for additional review. 1.1 Draft Deliverable Preparation Participating Role: Workgroup and Project Manager Timeline: As specified in the project-specific Scope of Work (SOW) or relevant contract language 1.1a: The Workgroup prepares a draft project deliverable in Microsoft Word under the supervision of the Workgroup leader(s) using the appropriate Mini-Sentinel template and submits the draft deliverable to the Project Manager for initial review by the MSOC Leadership. 1.1b: The Project Manager 1) ensures that Workgroup has the necessary materials and resources to prepare the deliverable, 2) oversees iterations of the draft deliverable between the Workgroup and the MSOC, 3) ensures that all relevant workgroup participants are engaged in the deliverable preparation process, and 4) submits for MSOC Leadership review. 1.2 Draft Deliverable Review by MSOC Leadership and Submission to FDA COTR Participating Role: MSOC Leadership Timeline: Within 2 weeks of receipt of the draft deliverable from the Workgroup MSOC Leadership performs the initial review of the draft deliverable. After deliverable has been approved by the MSOC Leadership, the deliverable is submitted to the FDA COTR via or secure portal. 1.3 Draft Deliverable Review by FDA COTR Participating Role: FDA COTR Timeline: Within two weeks of receipt of the draft deliverable from the MSOC 1 FDA COTR reviews the draft deliverable submitted by MSOC Leadership and returns it to the MSOC Leadership with comments and suggested revisions. 2 Final Deliverable Prepare final project deliverable, review and submit for FDA acceptance, and accept deliverable. 1 If it is anticipated that review will take longer than 2 weeks, FDA will notify MSOC Leadership prior to the due date. SOP - Deliverable Preparation March 15, 2012

7 2.1 Final Deliverable Preparation Participating Role: Workgroup and Project Manager Timeline: Within 2 weeks from receipt of the commented draft from MSOC 2 2.1a: The Workgroup revises the draft deliverable under the supervision of the Workgroup Leader(s). 2.1b: The Project Manager 1) ensures that the Workgroup has the necessary materials and resources to revise the deliverable, 2) if applicable, coordinates iterations of the draft deliverable, 3) ensures that all relevant workgroup participants are engaged in the deliverable revision process, and 4) ensures that the revised document displays tracked changes and incorporates both FDA comments and edits and the workgroup s revisions and responses. All revisions must be in MS Word track changes format using the commented draft received from FDA (step 1.2). Comments from FDA should remain in the document. All FDA comments must be addressed and a rationale provided in the comment box if no edits are made in response to a comment. Documents not revised with track changes will be returned. Two versions of the deliverable will be submitted to MSOC Leadership, one markup copy using MS Word track changes/comments and one clean copy without track changes. Workgroups should determine how to respond to FDA feedback based on the type of deliverable and the guidelines below: Scientific White papers or reports that are not specific to a safety signal assessment. All FDA comments must be addressed. The scientific discussion should adequately meet the needs of the FDA in terms of presentation of findings and any contextual information necessary for interpretation. Disagreements between the FDA and workgroups may be noted. Protocols developed for protocol-based assessments. While workgroups may not always be in agreement with the FDA perspective, the final protocol should reflect the scientific discussion and considerations that resulted in the development of a protocol that FDA intends to implement in order to inform regulatory decision making. A protocol should not be considered final until FDA intends to implement it as written. Protocols may require revisions based on data and methodological discussion during implementation. When revisions are necessary, the workgroup leader(s) shall provide these revisions within a change document template and adhere to the process outlined above for submission, review, and posting. 2 If it is anticipated that revision will take longer than 2 weeks, the Workgroup will notify the FDA COTR via the MSOC prior to the deadline and propose an alternative date. The workgroup will receive confirmation as to whether FDA will grant an extension as soon as possible after being notified. SOP - Deliverable Preparation March 15, 2012

8 Reports from protocol-based assessments. While workgroups may not always be in agreement with the FDA perspective, the final report should present the data and any necessary contextual information in a format that is useful to the FDA for interpretation of the findings. If the Workgroup chooses to provide any conclusions based on the findings of the assessment, the following statement should precede any discussion: The following is a discussion of the results of the Mini-Sentinel assessment of [insert topic]. However, this discussion does not take into account any other sources of information that the FDA may have available to inform a regulatory decision on this safety signal. Nor does it consider the larger public health impact of this medical product. The results of this assessment are intended to be used by the FDA in conjunction with other available information the FDA has to inform a regulatory decision (e.g., clinical development program, postmarket studies, and spontaneous reports). The Workgroup Leader(s) submits the draft final deliverable to the Project Manager for review by the MSOC Leadership. 2.2 Final Deliverable Review by MSOC Leadership and Submission to FDA COTR Participating Role: MSOC Leadership and Project Manager Timeline: Within 2 weeks of receipt of the draft-final deliverable from the Workgroup The Project Manager ensures that the draft-final deliverable displays tracked changes and incorporates FDA comments and edits as well as the workgroup s revisions and responses. MSOC Leadership and the Project Manager review and revise, as appropriate, the draft-final deliverable for consistency with standards as specified in the project-specific SOW or relevant contract language. MSOC Leadership submits both versions (clean and track change copies) of the draft final deliverable to FDA COTR for review and acceptance via or the secure portal. 2.3 Final Deliverable Acceptance by FDA COTR Participating Role: FDA COTR Timeline: Within 2 weeks of receipt of the final deliverable 1 FDA receives the final deliverable submitted by the Workgroup through the MSOC Leadership and accepts it as an official Mini-Sentinel work product. If the FDA COTR does not accept the final deliverable, return to Section 1.2 for the process for further revision. If there are revisions and/or comments remaining after the second revision, a conference call will be scheduled by the MSOC with the Workgroup Leader(s) and FDA COTR to identify and address any outstanding issues. 1 If it is anticipated that review will take longer than 2 weeks, FDA will notify MSOC Leadership prior to the due date. SOP - Deliverable Preparation March 15, 2012

9 3 Posting Deliverable Prepare project deliverable for posting on the Mini-Sentinel website ( submit to FDA for approval, authorize posting, and post. 3.1 Formatting Deliverable for Posting Participating Role: Webmaster and Project Manager Timeline: Within 2 weeks of receipt of the final deliverable The Webmaster and Project Manager, 1) proof the formatted deliverable, 2) review and revise if necessary to meet MSOC standards, 3) create a pdf version of the document, 4) check the pdf for compliance with Section 508 (adherence to accessibility standards), and 5) collaborate with the Workgroup to meet accessibility requirements, as necessary. 3.2 Approval of Formatted Deliverable by MSOC Leadership and Submission to FDA Sentinel Core Team for Review Participating Role: MSOC Timeline: Within 1 week of receipt of the final deliverable MSOC receives the formatted final deliverable from the Webmaster and notifies FDA Sentinel Core Team of impending posting. The MSOC provides the Sentinel Core Team with the final version of the deliverable and an anticipated posting date. 3.3 Approval of Formatted Deliverable for Posting by FDA Sentinel Core Team Participating Role: Sentinel Core Team Timeline: Within 1 week of receipt of the formatted deliverable from the MSOC Sentinel Core Team will review the formatted for posting deliverable and authorize the MSOC to post. If posting should be delayed for any reason, the Sentinel Core Team will provide notification to the MSOC. 3.4 Authorization of Deliverable for Posting by MSOC Participating Role: MSOC Timeline: Upon receipt of approval for posting by FDA s Sentinel Core Team MSOC authorizes the Webmaster to post the final deliverable on the Mini-Sentinel.org website. 3.5 Posting of Deliverable Participating Role: Webmaster Timeline: Within 1 week of authorization for posting by MSOC, or on the agreed upon posting date. The Webmaster and authorized MSOC personnel post the approved formatted final deliverable to the Mini-Sentinel website. The Webmaster and/or the authorized MSOC personnel will notify the Sentinel Core Team when deliverable has been posted. SOP - Deliverable Preparation March 15, 2012

Standard Operating Procedure for the Data Update Process. June 5, 2014 Version 2.0

Standard Operating Procedure for the Data Update Process. June 5, 2014 Version 2.0 Standard Operating Procedure for the Update Process June 5, 2014 Version 2.0 Table of Contents I. INTRODUCTION...1 II. PURPOSE AND SCOPE...1 III. ROLES AND RESPONSIBILITIES...1 IV. PROCESS ENABLERS...2

More information

Update From the Office of Surveillance and Epidemiology

Update From the Office of Surveillance and Epidemiology Update From the Office of Surveillance and Epidemiology Gerald J. Dal Pan, MD, MHS Director Office of Surveillance and Epidemiology Center for Drug Evaluation and Research Presentation to FDA-CMS Summit

More information

Software Cost. Discounted STS Rate Units Total $0.00 $0.00 $0.00 $0.00 Total $0.00

Software Cost. Discounted STS Rate Units Total $0.00 $0.00 $0.00 $0.00 Total $0.00 Cost Form This cost form has been provided to assist respondents in submitting costs associated by deliverable. Remember that all costs are to be the firm, fixed price of the deliverable and project total.

More information

We are recruiting for summer unpaid internships (hours and dates of internship are flexible)

We are recruiting for summer unpaid internships (hours and dates of internship are flexible) Minimum of 12 hours a week/unpaid Internship The Green Lab Alliance is an emerging non-profit operating in Seattle whose mission is to Identify, validate, and diffuse emerging laboratory best practices

More information

Voice Over IP Network Solution Design, Testing, Integration and Implementation Program Overview

Voice Over IP Network Solution Design, Testing, Integration and Implementation Program Overview Voice Over IP Network Solution Design, Testing, Integration and Implementation Program Overview 1/1 Table of Contents 1. Introduction...3 2. Executive Summary...4 3. Program Definition...5 3.1. Program

More information

POLICY AND PROCEDURES OFFICE OF NEW DRUGS. NDAs and BLAs: Communication to Applicants of Planned Review Timelines.

POLICY AND PROCEDURES OFFICE OF NEW DRUGS. NDAs and BLAs: Communication to Applicants of Planned Review Timelines. CENTER FOR DRUG EVALUATION AND RESEARCH MAPP 6010.8 Rev. 1 POLICY AND PROCEDURES OFFICE OF NEW DRUGS NDAs and BLAs: Communication to Applicants of Planned Review Timelines Table of Contents PURPOSE...1

More information

Regulated Documents. A concept solution for SharePoint that enables FDA 21CFR part 11 compliance when working with digital documents

Regulated Documents. A concept solution for SharePoint that enables FDA 21CFR part 11 compliance when working with digital documents Regulated Documents A concept solution for SharePoint that enables FDA 21CFR part 11 compliance when working with digital documents Contents Life science industry challenges Regulated Documents our service

More information

Fast Forward Proposal Template - January 2016

Fast Forward Proposal Template - January 2016 Fast Forward Proposal Template - January 2016 NOTE: A new grants management system called MS Grants has been implemented for preparation and submission of research proposals to the Society. MS Grants can

More information

STANDARD OPERATING PROCEDURE NO. CM.13-00 - 00

STANDARD OPERATING PROCEDURE NO. CM.13-00 - 00 STANDARD OPERATING PROCEDURE NO. CM.13-00 - 00 Version date: Effective Date: Replaces SOP No.: 1 5 January 20 13 15 February 20 13 Approved by: Date No: CM.13 00 00 Effective Date: 15 February 2013 Version

More information

EU Clinical Trials Regulation Regulation EU 536/2014

EU Clinical Trials Regulation Regulation EU 536/2014 EU Clinical Trials Regulation Regulation EU 536/2014 María Jesús Zafra Director, QA & Compliance Table of contents 1 2 3 4 Introduction Timelines and main changes Highlights 5 Impact on company processes

More information

Managed Service Solutions Catalogue. MANAGED SERVICES SOLUTIONS CATALOGUE MS Offering Overview June 2014

Managed Service Solutions Catalogue. MANAGED SERVICES SOLUTIONS CATALOGUE MS Offering Overview June 2014 Managed Service Solutions Catalogue MANAGED SERVICES SOLUTIONS CATALOGUE MS Offering Overview June 2014 1 MANAGED SERVICES SOLUTIONS CATALOGUE Managed Services Solutions Catalogue Managed Service Solutions

More information

FDA's Mini-Sentinel Program to Evaluate the Safety of Marketed Medical Products. Progress and Direction

FDA's Mini-Sentinel Program to Evaluate the Safety of Marketed Medical Products. Progress and Direction FDA's Mini-Sentinel Program to Evaluate the Safety of Marketed Medical Products Progress and Direction Richard Platt Harvard Pilgrim Health Care Institute Harvard Medical School for the Mini-Sentinel Investigators

More information

Questions and answers on post approval change management protocols

Questions and answers on post approval change management protocols 27 October 2010 EMA/CHMP/CVMP/QWP/586330/2010 Questions and answers on post approval change management protocols Draft Draft Agreed by QWP September 2010 Adoption by CHMP for release for consultation 23

More information

Frequently Asked Questions for: Settlement Disputes System Submittal Process

Frequently Asked Questions for: Settlement Disputes System Submittal Process Frequently Asked Questions for: Settlement Disputes System Submittal Process California ISO. Copyright 2011. All Rights Reserved TABLE OF CONTENTS SETTLEMENT DISPUTE SYSTEM... 3 Q1: What is a settlement

More information

Lucy Malby Business Development Manager eg technology Ltd

Lucy Malby Business Development Manager eg technology Ltd Lucy Malby Business Development Manager eg technology Ltd Design review, engineering prototype and design freeze Pre- clinical unit verification, clinical unit validation Engineering Prototype What is

More information

Questions and answers on post approval change management protocols

Questions and answers on post approval change management protocols 30 March 2012 EMA/CHMP/CVMP/QWP/586330/2010 Committee for Medicinal Products for Human Use (CHMP) Questions and answers on post approval change management protocols Draft agreed by CHMP / CVMP Quality

More information

Modular Program Report

Modular Program Report Modular Program Report The following report(s) provides findings from an FDA initiated query using its Mini Sentinel pilot. While Mini Sentinel queries may be undertaken to assess potential medical product

More information

STUDENT PORTAL - TURNITIN

STUDENT PORTAL - TURNITIN Online STUDENT PORTAL - TURNITIN Student Manual Ver. 5 London School of Commerce & School of Business and Law IT Department 2012 1 What is new in STUDENT PORTAL? www.lsclondon.co.uk/student/studentmanual.pdf

More information

IMEDS-Evaluation for Conducting Post-Market Safety Studies

IMEDS-Evaluation for Conducting Post-Market Safety Studies IMEDS-Evaluation for Conducting Post-Market Safety Studies Susan Gruber Troy McCall, Greg Daniel *, Nicole Spear Reagan-Udall Foundation for the FDA * Brookings Institution Big DiP USA, Boston, Massachusetts,

More information

Old Phase Description New Phase Description

Old Phase Description New Phase Description Prologue This amendment of The FAA and Industry Guide to Product Certification (CPI Guide) incorporates changes based on lessons learned and supports the broader use of this guide by providing additional

More information

U.S. DEPARTMENT OF THE INTERIOR. Ordering Guide. Microsoft SharePoint Support Services BPA

U.S. DEPARTMENT OF THE INTERIOR. Ordering Guide. Microsoft SharePoint Support Services BPA U.S. DEPARTMENT OF THE INTERIOR Ordering Guide Microsoft SharePoint Support Services BPA U.S. Fish & Wildlife Service Division of Contracting and Facilities Management 4401 North Fairfax Drive, MS 7118-43

More information

SITE PLAN APPROVAL PROCESS INTRODUCTION

SITE PLAN APPROVAL PROCESS INTRODUCTION SITE PLAN APPROVAL PROCESS INTRODUCTION File Manager System for Site Plan Approval Process Site Plan Control in the City of London The City of London utilizes site plan control to ensure high quality site

More information

A PROPOSAL TO PRODUCE A CAPABILITY BROCHURE FOR SECURITY FINANCIAL SERVICES

A PROPOSAL TO PRODUCE A CAPABILITY BROCHURE FOR SECURITY FINANCIAL SERVICES A PROPOSAL TO PRODUCE A CAPABILITY BROCHURE FOR SECURITY FINANCIAL SERVICES Prepared for Sally D. Client Director of Marketing Support (date) CONTENTS Assignment Background page 3 Assignment Objectives

More information

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS GUIDELINE FOR THE CONDUCT OF POST-MARKETING SURVEILLANCE STUDIES OF VETERINARY MEDICINAL PRODUCTS

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS GUIDELINE FOR THE CONDUCT OF POST-MARKETING SURVEILLANCE STUDIES OF VETERINARY MEDICINAL PRODUCTS The European Agency for the Evaluation of Medicinal Products Veterinary Medicines and Information Technology EMEA/CVMP/044/99-FINAL COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS GUIDELINE FOR THE CONDUCT

More information

Health Products and Food Branch. www.hc-sc.gc.ca

Health Products and Food Branch. www.hc-sc.gc.ca Health Products and Food Branch 1 HEALTH CANADA PART C DIVISION 5 - DRUGS FOR CLINICAL TRIALS INVOLVING HUMAN SUBJECTS Part C - Division 5 2 Part A: Part B: Part C: Part D: Part E: Part G: Part J: Administration

More information

Section 1 Project Management, Project Communication/Process Design, Mgmt, Documentation, Definition & Scope /CRO-Sponsor Partnership

Section 1 Project Management, Project Communication/Process Design, Mgmt, Documentation, Definition & Scope /CRO-Sponsor Partnership Section 1 Project Management, Project Communication/Process Design, Mgmt, Documentation, Definition & Scope /CRO-Sponsor Partnership PROJECT MANAGEMENT - SCOPE DEFINITION AND MANAGEMENT Understands the

More information

IOWA DEPARTMENT OF PUBLIC HEALTH EMERGENCY MEDICAL SERVICES (EMS) SYSTEM DEVELOPMENT GRANT

IOWA DEPARTMENT OF PUBLIC HEALTH EMERGENCY MEDICAL SERVICES (EMS) SYSTEM DEVELOPMENT GRANT IOWA DEPARTMENT OF PUBLIC HEALTH EMERGENCY MEDICAL SERVICES (EMS) SYSTEM DEVELOPMENT GRANT APPLICATION INSTRUCTIONS AND APPLICATION FORMS FOR CONTRACT YEAR OF: SEPTEMBER 1, 2013 TO JUNE 30, 2014 Application

More information

PROTOCOL FOR THE PILOT STUDY OF HEALTH LEVEL 7 MESSAGE-EXCHANGE BETWEEN IMMUNIZATION INFORMATION SYSTEMS AND MINI-SENTINEL/PRISM DATA PARTNERS

PROTOCOL FOR THE PILOT STUDY OF HEALTH LEVEL 7 MESSAGE-EXCHANGE BETWEEN IMMUNIZATION INFORMATION SYSTEMS AND MINI-SENTINEL/PRISM DATA PARTNERS PROTOCOL FOR THE PILOT STUDY OF HEALTH LEVEL 7 MESSAGE-EXCHANGE BETWEEN IMMUNIZATION INFORMATION SYSTEMS AND MINI-SENTINEL/PRISM DATA PARTNERS Prepared by: Therese Hoyle, BSHE 1, Carolyn Jevit, MBA 2,

More information

IRB Submissions and Human Subjects Research Compliance. Georgia Health Sciences University

IRB Submissions and Human Subjects Research Compliance. Georgia Health Sciences University IRB Submissions and Human Subjects Research Compliance Offi f H R hp t ti Office of Human Research Protection Georgia Health Sciences University Objectives Identify the steps required to submit a protocol

More information

Request for Proposals. SFY 2014 Section 604(b) Water Quality Planning Pass-Through Grant Program

Request for Proposals. SFY 2014 Section 604(b) Water Quality Planning Pass-Through Grant Program Request for Proposals SFY 2014 Section 604(b) Water Quality Planning Pass-Through Grant Program State of New Jersey Department of Environmental Protection Water Resources Management Division of Water Monitoring

More information

AssessingYourCreative ReviewandApprovalProcess

AssessingYourCreative ReviewandApprovalProcess AssessingYourCreative ReviewandApprovalProcess Introduction All marketing organizations have a review and approval process of some sort, with approaches ranging from informal and ad-hoc to formalized and

More information

Child Care Provider Preparation Guide

Child Care Provider Preparation Guide Child Care Provider Preparation Guide North Carolina Department of Health and Human Services Families Accessing Services through Technology (NC FAST) February 2016 Version 1.0 Page 1 of 17 TABLE OF CONTENTS

More information

A Complete Drug Stability Program. Stability Lab Information Manager SL IM

A Complete Drug Stability Program. Stability Lab Information Manager SL IM A Complete Drug Stability Program Stability Lab Information Manager SL IM SLIM is a Fully Validated, World-Class Stability LIMS. SLIM combines the ease of use of browser style user interface and industry

More information

Department of Administration Portfolio Management System 1.3 June 30, 2010

Department of Administration Portfolio Management System 1.3 June 30, 2010 E 06/ 30/ 2010 EX AM PL 1. 3 06/ 28/ 2010 06/ 24/ 2010 06/ 23/ 2010 06/ 15/ 2010 06/ 18/ 2010 Portfolio System 1.3 June 30, 2010 Contents Section 1. Project Overview... 1 1.1 Project Description... 1 1.2

More information

Vertiply Compliance An introduction to comprehensive compliance management software

Vertiply Compliance An introduction to comprehensive compliance management software Vertican Technologies, Inc. Vertiply Compliance An introduction to comprehensive compliance management software Stevan H. Goldman Kurt Sund President and CEO Chief Technology Officer Vertican Technologies,

More information

Roadmap for study startup

Roadmap for study startup How-To Guide Roadmap for study startup Deploying Adobe technology to automate clinical study startup procedures Section 1: Introduction and overview 2 1.1 Introduction 2 1.2 Overview of the clinical study

More information

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP)

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) European Medicines Agency Pre-authorisation Evaluation of Medicines for Human Use London, 17 July 2006 Doc. Ref. EMEA/419127/05 COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON THE PROCEDURE

More information

Quality Management Plan

Quality Management Plan Quality Management Plan 6666 West Quincy Avenue Denver, Colorado 80235-3098 Telephone (303) 347-6100 September 1, 2011 CONTENTS Page APPROVALS ACRONYMS AND ABBREVIATIONS ii vi 1 INTRODUCTION 1 2 FOUNDATION

More information

February 2006 Procedural

February 2006 Procedural Guidance for Industry Reports on the Status of Postmarketing Study Commitments Implementation of Section 130 of the Food and Drug Administration Modernization Act of 1997 U.S. Department of Health and

More information

RFQ 6100021446 PKI Assessment and Design Questions and Answers

RFQ 6100021446 PKI Assessment and Design Questions and Answers RFQ 6100021446 PKI Assessment and Design Questions and Answers 1. Is there a list of bidders for this solicitation which minority and women businesses can access to reach out for teaming? The IT ITQ website

More information

Establishment of a Quality Systems approach to Clinical Site Management An Overview of Standard Operating Procedures (SOPs)

Establishment of a Quality Systems approach to Clinical Site Management An Overview of Standard Operating Procedures (SOPs) Establishment of a Quality Systems approach to Clinical Site Management An Overview of Standard Operating Procedures (SOPs) Cornelia Kamp, MBA Executive Director Strategic Initiatives Tim Hackett Director

More information

TERMS OF REFERENCE (TORs)

TERMS OF REFERENCE (TORs) TERMS OF REFERENCE (TORs) OVERVIEW TITLE LOCATION OF ASSIGNMENT LANGUAGE(S) REQUIRED TRAVEL DURATION OF CONTRACT SECTION & UNIT CONSULTANT REPORTING TO Data Science Researcher & Lead analyst for Information

More information

Guide for Agents* *Please note that agent refers to anyone authorized by the homeowner to represent them during the short sale process

Guide for Agents* *Please note that agent refers to anyone authorized by the homeowner to represent them during the short sale process Equator for Short Sales: Guide for Agents* A self guided tour of our Equator system with tips on optimal use and a view into the Homeowners portal, positioning you to confidently assist your clients through

More information

FIPS 201 Evaluation Program Development - Configuration Management Plan

FIPS 201 Evaluation Program Development - Configuration Management Plan FIPS 201 Evaluation Program Development - Configuration Management Plan Version 1.0.0 February 28, 2006 Document History Status Version Date Comment Audience Draft 0.0.1 02/01/06 Document creation. Limited

More information

Institution Workspace

Institution Workspace Accreditation Information Management System Institution Workspace Frank Huang March, 2016 AIMS Overview The Accreditation Information Management System (AIMS), designed and developed in-house, has benefitted

More information

Roles & Responsibilities of the Sponsor

Roles & Responsibilities of the Sponsor Roles & Responsibilities of the Sponsor Developed by Center for Cancer Research, National Cancer Institute, NIH Endorsed by the CTN SIG Leadership Group Objectives Funding for clinical research comes from

More information

JTC INNOVATION GRANT CALL ON SUSTAINABLE SOLUTIONS

JTC INNOVATION GRANT CALL ON SUSTAINABLE SOLUTIONS JTC INNOVATION GRANT CALL ON SUSTAINABLE SOLUTIONS 1. PROBLEM STATEMENT Develop and pilot innovative solutions that improve the productivity and reduce the reliance on manpower, including sustainable solutions

More information

GRANT REQUEST FOR PROPOSAL. Issued By. Minnesota Board of Pharmacy

GRANT REQUEST FOR PROPOSAL. Issued By. Minnesota Board of Pharmacy GRANT REQUEST FOR PROPOSAL Issued By Minnesota Board of Pharmacy Project Title: Integration of Access to the MN Prescription Monitoring Program Database into the Clinical Workflow via the Electronic Medical

More information

Project Information Forms. Protocols and Support for Licensed Archaeologists Using Ontario s Past Portal

Project Information Forms. Protocols and Support for Licensed Archaeologists Using Ontario s Past Portal Project Information Forms Protocols and Support for Licensed Archaeologists Using Ontario s Past Portal Ministry of Tourism, Culture and Sport 2013 Contact us: If you have any questions or concerns about

More information

Fair Registration Practices Report

Fair Registration Practices Report Fair Registration Practices Report Pharmacy Technicians (2011) The answers that you submitted to OFC can be seen below. This Fair Registration Practices Report was produced as required by: the Fair Access

More information

PharmaSUG 2016 Paper IB10

PharmaSUG 2016 Paper IB10 ABSTRACT PharmaSUG 2016 Paper IB10 Moving from Data Collection to Data Visualization and Analytics: Leveraging CDISC SDTM Standards to Support Data Marts Steve Kirby, JD, MS, Chiltern, King of Prussia,

More information

Standard Operating Procedures (SOP) for: Reporting of Serious Breaches of GCP or the Trial Protocol sponsored CTIMP s. Lisa Austin, Research Manager

Standard Operating Procedures (SOP) for: Reporting of Serious Breaches of GCP or the Trial Protocol sponsored CTIMP s. Lisa Austin, Research Manager Standard Operating Procedures (SOP) for: Reporting of Serious Breaches of GCP or the Trial Protocol sponsored CTIMP s Author: Lisa Austin, Research Manager Purpose and Objective: To identify and standardise

More information

RFP #TA-10: Implementation of the Diagnostic Tool for School and District Effectiveness. Questions and Answers

RFP #TA-10: Implementation of the Diagnostic Tool for School and District Effectiveness. Questions and Answers RFP #TA-10: Implementation of the Diagnostic Tool for School and District Effectiveness Questions and Answers FISCAL 1. Question: Is there a budget range allocated to this initiative? If a budget has been

More information

The Program Assessment Process

The Program Assessment Process Commission on Teacher Credentialing 1900 Capitol Avenue Sacramento, CA 95811 (916) 324-8002 Fax (916) 324-8927 www.ctc.ca.gov June 22, 2011 Ms. Teresa Stringer Irvine Unified School District (535) 5050

More information

What is Clinical Data Management

What is Clinical Data Management What is Clinical Data Management Clinical Data Management is involved in all aspects of processing the clinical data, working with a range of computer applications, database systems to support collection,

More information

Pisces Status Reporting Training Materials September 2005, updated March 2006

Pisces Status Reporting Training Materials September 2005, updated March 2006 Status Reporting in Pisces G Y R Online status reporting is now available in Pisces Beginning with the month of July 2005, and the July-September quarter, contractors may complete and submit status reports

More information

Request for Service. Business and Technical Consulting Services Senior Business Analyst OntarioMD EMR Physician Dashboard

Request for Service. Business and Technical Consulting Services Senior Business Analyst OntarioMD EMR Physician Dashboard Request for Service Business and Technical Consulting Services Senior Business Analyst OntarioMD EMR Physician Dashboard RFS Number: 2015-11 Issued: October 29, 2015 Closing Date: November 12, 2015 at

More information

Document Title: Trust Approval and Research Governance

Document Title: Trust Approval and Research Governance Document Title: Trust Approval and Research Governance Document Number: SOP034 Staff involved in development: Job titles only Document author/owner: Directorate: Department: For use by: RM&G Manager, R&D

More information

https://www.fbo.gov/index?s=opportunity&mode=form&id=682b18787a8886f6ce36a118...

https://www.fbo.gov/index?s=opportunity&mode=form&id=682b18787a8886f6ce36a118... Page 1 of 6 Clinical Studies Monitoring Service (CSMS) National Center for Complementary and Integrative Health (NCCIH) Solicitation Number: HHSNI-NCISBSSTSB5701304 Agency: Department of Health and Human

More information

SYSTEM DEVELOPMENT AND IMPLEMENTATION

SYSTEM DEVELOPMENT AND IMPLEMENTATION CHAPTER 6 SYSTEM DEVELOPMENT AND IMPLEMENTATION 6.0 Introduction This chapter discusses about the development and implementation process of EPUM web-based system. The process is based on the system design

More information

Questions & answers on signal management

Questions & answers on signal management 23 October 2015 EMA/261758/2013 Inspections and Human Medicines Pharmacovigilance Division This document addresses a number of questions which stakeholders, in particular marketing authorisation holders

More information

Study Start-Up SS-204.01. STANDARD OPERATING PROCEDURE FOR Site Initiation Visit (SIV)

Study Start-Up SS-204.01. STANDARD OPERATING PROCEDURE FOR Site Initiation Visit (SIV) Study Start-Up SS-204.01 STANDARD OPERATING PROCEDURE FOR Site Initiation Visit (SIV) Approval: Nancy Paris, MS, FACHE President and CEO 08 March 2012 (Signature and Date) Approval: Frederick M. Schnell,

More information

EBA/ITS/2016/01. 13 January 2016. Final Report

EBA/ITS/2016/01. 13 January 2016. Final Report EBA/ITS/2016/01 13 January 2016 Final Report Final draft implementing technical standards amending the Commission Implementing Regulation (EU) No 1030/2014 on the uniform formats and date for the disclosure

More information

Request for Proposal For Document Management System

Request for Proposal For Document Management System Request for Proposal For Document Management System June 13, 2014 1708 East Arlington Blvd. Greenville, NC 27858-5872 This solicitation should not be interpreted as a contract (implicit, explicit, or implied),

More information

Regulatory Affairs Professional Development Framework AN OVERVIEW

Regulatory Affairs Professional Development Framework AN OVERVIEW Regulatory Affairs Professional Development Framework AN OVERVIEW TABLE OF CONTENTS Abstract...2 Introduction...2 Approach...3 Professional Development Framework...3 Professional Levels...3 Domains...4

More information

Document Management. User Guide. Etz Support Team June 2012

Document Management. User Guide. Etz Support Team June 2012 Document Management User Guide Etz Support Team June 2012 This guide shows how to set up your Document Management module and explains how to apply and manage documents through your Etz system. Contents

More information

Research Coordinator - PI s who have research coordinators or secretarial support can designate individuals to manage their IRB protocols in Mentor.

Research Coordinator - PI s who have research coordinators or secretarial support can designate individuals to manage their IRB protocols in Mentor. Mentor Online IRB System IRB s require lots of documentation and managing this process can get to be a burden for both investigators and the IRB committee and administrator. The Mentor IRB system is designed

More information

Medical Portal Treatment Authorization Requests (TARs) January 2016

Medical Portal Treatment Authorization Requests (TARs) January 2016 Medical Portal Treatment Authorization Requests (TARs) January 2016 Why do we need the Medical Portal? 2 Today vs Tomorrow s Medical Authorization Process 3 Today Provider Needs To Request Authorization

More information

STRENGTHENING OUR NATIONAL SYSTEM FOR MEDICAL DEVICE POSTMARKET SURVEILLANCE

STRENGTHENING OUR NATIONAL SYSTEM FOR MEDICAL DEVICE POSTMARKET SURVEILLANCE STRENGTHENING OUR NATIONAL SYSTEM FOR MEDICAL DEVICE POSTMARKET SURVEILLANCE UPDATE AND NEXT STEPS CENTER FOR DEVICES AND RADIOLOGICAL HEALTH U.S. FOOD AND DRUG ADMINISTRATION APRIL 2013 BACKGROUND In

More information

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON DATA MONITORING COMMITTEES

COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE ON DATA MONITORING COMMITTEES European Medicines Agency Pre-authorisation Evaluation of Medicines for Human Use London, 27 July 2005 Doc. Ref. EMEA/CHMP/EWP/5872/03 Corr COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE (CHMP) GUIDELINE

More information

MOREHOUSE SCHOOL OF MEDICINE

MOREHOUSE SCHOOL OF MEDICINE MOREHOUSE SCHOOL OF MEDICINE TO: FROM: Applicants to Entering Classes in the Programs (Ph.D. in Biomedical Sciences, M.S. in Clinical Research, M.S. in Biomedical Sciences, M.S. in Biomedical Technology,

More information

Guideline on good pharmacovigilance practices (GVP)

Guideline on good pharmacovigilance practices (GVP) 1 2 20 February 2012 EMA/541760/2011 3 4 Guideline on good pharmacovigilance practices (GVP) Module I Pharmacovigilance systems and their quality systems Draft finalised by the Agency in collaboration

More information

Clinical Data Management is involved in all aspects of processing the clinical data, working with a range of computer applications / database systems

Clinical Data Management is involved in all aspects of processing the clinical data, working with a range of computer applications / database systems Clinical Data Management is involved in all aspects of processing the clinical data, working with a range of computer applications / database systems to support collection, cleaning and management of subject

More information

ORACLE CONSULTING GROUP

ORACLE CONSULTING GROUP ORACLE CONSULTING GROUP An Official United States Agent Firm for Foreign Establishments CONSULTING MEMORANDUM: DEALING WITH A MEDICAL DEVICE IN THE U.S. 5398 Golder Ranch Rd., Ste. 1 Tucson, Arizona 85739

More information

Table of Contents EXECUTIVE SUMMARY... 1

Table of Contents EXECUTIVE SUMMARY... 1 Table of Contents EXECUTIVE SUMMARY... 1 I. SENTINEL SYSTEM VISION... 3 A. Active surveillance via a distributed system... 3 B. Sentinel will expand FDA s current safety surveillance capabilities... 3

More information

Pulmonary Rehabilitation Proposal for On-Line Competencies

Pulmonary Rehabilitation Proposal for On-Line Competencies Pulmonary Rehabilitation Proposal for On-Line Competencies Fran Strauss MIT 520 December 7, 2006 Executive Summary Pulmonary Rehabilitation (PR) is a department within the Coastal Heart Division of New

More information

Research Guidelines for the Master of Science in Nursing. Northern Michigan University College of Professional Studies Department of Nursing

Research Guidelines for the Master of Science in Nursing. Northern Michigan University College of Professional Studies Department of Nursing Research Guidelines for the Master of Science in Nursing Northern Michigan University College of Professional Studies Department of Nursing May 2007 Table of Contents Introduction.. 4 Project Options..

More information

EFPIA Principles for the Development of the EU Clinical Trials Portal and Database

EFPIA Principles for the Development of the EU Clinical Trials Portal and Database Position Paper EFPIA Principles for the Development of the EU Clinical Trials Portal and Database Executive summary EFPIA sees the implementation of the Clinical Trials Regulation 1 as an opportunity to

More information

005. Independent Review Organization External Review Annual Report Form

005. Independent Review Organization External Review Annual Report Form Title 210 NEBRASKA DEPARTMENT OF INSURANCE Chapter 87 HEALTH CARRIER EXTERNAL REVIEW 001. Authority This regulation is adopted by the director pursuant to the authority in Neb. Rev. Stat. 44-1305 (1)(c),

More information

1 OPPORTUNITY SUMMARY

1 OPPORTUNITY SUMMARY REQUEST FOR PROPOSALS: SOFTWARE IMPLEMENTATION PROJECT MANAGEMENT SERVICES Posting Date: Wednesday, September 23, 2015 Due Date: Tuesday, October 13, 2015 1 OPPORTUNITY SUMMARY The Massachusetts Clean

More information

Contractor. Management

Contractor. Management Contractor Environment Health and Safety Management Best Practice (2007) A. INTRODUCTION Many construction Owners employ contract personnel for a wide range of activities, from administrative support to

More information

GUIDELINES FOR DOCTORAL STUDENT PARTICIPATION IN GRADUATION CEREMONY AND PROGRESS TO DEGREE AWARD

GUIDELINES FOR DOCTORAL STUDENT PARTICIPATION IN GRADUATION CEREMONY AND PROGRESS TO DEGREE AWARD 2015 Frostburg State University Office of Graduate Services GUIDELINES FOR DOCTORAL STUDENT PARTICIPATION IN GRADUATION CEREMONY AND PROGRESS TO DEGREE AWARD 1 REV 1 30 15 Table of Contents Expectations

More information

QUALITY ASSURANCE PROGRAM

QUALITY ASSURANCE PROGRAM QUALITY ASSURANCE PROGRAM TICKLER GUIDELINES AND PROCEDURE NOTE: Although the QAP Steering Committee has not had an opportunity to review in detail the Tickler Guidelines and Procedure, it agrees in principle

More information

RE AP QUE PLIC FOR IONS. Compa CPRIT RFA C 12 FORM 2. Company. p.1/17

RE AP QUE PLIC FOR IONS. Compa CPRIT RFA C 12 FORM 2. Company. p.1/17 RE AP QUE ST PLIC AT RFA C 12 FORM 2 FOR IONS Compa any Formation Awards FY 2012 Fiscal Year Award Period September 1, 2011 Augustt 31, 2012 CPRIT RFA C 12 FORM 2 (Rev 6/ /30/11) Company Formation Awards

More information

CLINICAL DATA MONITORING PLAN (CDMoP) PROTOCOL # [0000] [TITLE]

CLINICAL DATA MONITORING PLAN (CDMoP) PROTOCOL # [0000] [TITLE] CLINICAL DATA MONITORING PLAN (CDMoP) PROTOCOL # [0000] [TITLE] CONTRACT RESEARCH ORGANIZATION SPONSOR [NAME] [ADDRESS] 1 TABLE OF CONTENTS 1. Purpose 3 2. References 3 3. Study Roles and Responsibilities

More information

DRAFT FOR DISCUSSION ONLY

DRAFT FOR DISCUSSION ONLY Working Group Action Plan Initiative DELIVERABLE OUTCOME Task Team Members Personal Care products and Pharmaceuticals Common Electronic Submission Gateway Implementation of a Common Electronic Submission

More information

Release of Data from EORTC Studies for Use in External Research Projects

Release of Data from EORTC Studies for Use in External Research Projects Release of Data from Studies for Use in External Research Projects POL008 Version 2.03 ALWAYS REFER TO THE INTERNET WEBSITE TO CHECK THE VALIDITY OF THIS DOCUMENT Author: Associate Head of Statistics Department

More information

Guidance Medication Guides Distribution Requirements and Inclusion in Risk Evaluation and Mitigation Strategies (REMS)

Guidance Medication Guides Distribution Requirements and Inclusion in Risk Evaluation and Mitigation Strategies (REMS) Guidance s Distribution Requirements and Inclusion in Risk Evaluation and Mitigation Strategies (REMS) U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation

More information

Serious Breaches. Ian Gravenor. Senior Clinical Project Manager Novo Nordisk Ltd

Serious Breaches. Ian Gravenor. Senior Clinical Project Manager Novo Nordisk Ltd Serious Breaches Ian Gravenor Senior Clinical Project Manager Novo Nordisk Ltd Serious Breaches of GCP or the Trial Protocol Agenda Why report? The legislation MHRA Guidance document Timelines Actions

More information

Subj: Appointment as a Contracting Officer's Technical Representative (COTR)

Subj: Appointment as a Contracting Officer's Technical Representative (COTR) Attachment (1) Agency/Component letterhead Subj: Appointment as a Contracting Officer's Technical Representative (COTR) From: (Insert name of Contracting Officer) To: (Insert name of prospective COTR)

More information

PMAs, 510(k)s, and Advanced IDE Topics

PMAs, 510(k)s, and Advanced IDE Topics PMAs, 510(k)s, and Advanced IDE Topics Kenneth J. Cavanaugh Jr., Ph.D. Scientific Reviewer Division of Cardiovascular Devices Office of Device Evaluation Center for Devices and Radiological Health kenneth.cavanaugh@fda.hhs.gov

More information

CLINICAL RESEARCH GENERIC TASK DESCRIPTIONS

CLINICAL RESEARCH GENERIC TASK DESCRIPTIONS Purpose Purpose Purpose Primary responsibility for implementation, coordination, evaluation, communication and/or management of research studies. May involve more than one study or multiple sites within

More information

Rediscover business simplicity with TULIP! Bring all your accounting, payroll & HR processes together under one platform

Rediscover business simplicity with TULIP! Bring all your accounting, payroll & HR processes together under one platform Rediscover business simplicity with TULIP! Bring all your accounting, payroll & HR processes together under one platform What is TULIP? Business process optimization solution developed by working closely

More information

Task Force on the Utilization of Science in Regulatory Decision Making. Preliminary Report and Recommendations

Task Force on the Utilization of Science in Regulatory Decision Making. Preliminary Report and Recommendations CDRH PRELIMINARY INTERNAL EVALUATIONS VOLUME II Task Force on the Utilization of Science in Regulatory Decision Making Preliminary Report and Recommendations August 2010 Center for Devices and Radiological

More information

The Fort McMurray Catholic Board of Education is committed to the protection of our employees, contractors, volunteers and the students we serve.

The Fort McMurray Catholic Board of Education is committed to the protection of our employees, contractors, volunteers and the students we serve. Fort McMurray Catholic Schools Operating Policies and Procedures OP 150 Occupational Health & Safety Policy The Fort McMurray Catholic Board of Education is committed to the protection of our employees,

More information

DRAFT Utah HCBS Setting Transition Plan

DRAFT Utah HCBS Setting Transition Plan DRAFT Utah HCBS Setting Transition Plan Section 1. Public Notice and Comment Process Action Item Description Proposed Make at least two statements of public notice that include a description of procedures

More information

Document Control SOP. Document No: SOP_0103 Prepared by: David Brown. Version: 10

Document Control SOP. Document No: SOP_0103 Prepared by: David Brown. Version: 10 1.0 Commercial in Confidence 16-Aug-2006 1 of 6 Document Control SOP Document No: SOP_0103 Prepared by: David Brown Date: 16-Aug-2006 Version: 10 1.0 Commercial in Confidence 16-Aug-2006 2 of 6 Document

More information

Guide to Assessment and Rating for Regulatory Authorities

Guide to Assessment and Rating for Regulatory Authorities Guide to Assessment and Rating for Regulatory Authorities January 2013 Copyright The details of the relevant licence conditions are available on the Creative Commons website (accessible using the links

More information

Guidance for Industry Planning for the Effects of High Absenteeism to Ensure Availability of Medically Necessary Drug Products

Guidance for Industry Planning for the Effects of High Absenteeism to Ensure Availability of Medically Necessary Drug Products Guidance for Industry Planning for the Effects of High Absenteeism to Ensure Availability of Medically Necessary Drug Products U.S. Department of Health and Human Services Food and Drug Administration

More information

A Blue Horse Initiative

A Blue Horse Initiative A Blue Horse Initiative THE HEALTHY MINDS COOPERATIVE REQUEST FOR PROPOSALS (RFP) ACCOUNTING SOFTWARE AND SERVICES ISSUE DATE: December 2, 2014 CLOSING DATE: December 18, 2014, 4:00 pm (A.S.T.) CONTACT

More information